A recent large intervention study has showed no effect of dietary doses of n3 fatty acids (FA) on global cognitive decline in coronary heart disease patients [1]. N3-FA, which include α-linoleic acid, eicosapentaenoic acid (EPA) and docosapentaenoic acid (DHA) (Figure 1), have been subject of intense investigation in the recent years for expected benefits in delaying cognitive decline. Previous epidemiological and experimental animal studies suggested that deficiency in n3-FA, in particular DHA that is one of the most represented fatty acid in the brain, accelerates cognitive decline and increases the risk of developing AD [2-7]. With the Geleijnse’s trial, is it enough to suggest stopping investigation on n3-FA in the context of cognitive decline in man?

N3 Fatty Acids and Neurodegeneration: Is it Enough to Stop or to Shift? / Iuliano, Luigi; Palmaccio, Giuseppina; Annagiulia, Bottaccioli; Zerbinati, Chiara. - In: JOURNAL OF ALZHEIMER’S DISEASE & PARKINSONISM. - ISSN 2161-0460. - ELETTRONICO. - 2:(2012), p. 1000e119. [10.4172/2161-0460.1000e119]

N3 Fatty Acids and Neurodegeneration: Is it Enough to Stop or to Shift?

IULIANO, Luigi;palmaccio, giuseppina;ZERBINATI, CHIARA
2012

Abstract

A recent large intervention study has showed no effect of dietary doses of n3 fatty acids (FA) on global cognitive decline in coronary heart disease patients [1]. N3-FA, which include α-linoleic acid, eicosapentaenoic acid (EPA) and docosapentaenoic acid (DHA) (Figure 1), have been subject of intense investigation in the recent years for expected benefits in delaying cognitive decline. Previous epidemiological and experimental animal studies suggested that deficiency in n3-FA, in particular DHA that is one of the most represented fatty acid in the brain, accelerates cognitive decline and increases the risk of developing AD [2-7]. With the Geleijnse’s trial, is it enough to suggest stopping investigation on n3-FA in the context of cognitive decline in man?
2012
01 Pubblicazione su rivista::01a Articolo in rivista
N3 Fatty Acids and Neurodegeneration: Is it Enough to Stop or to Shift? / Iuliano, Luigi; Palmaccio, Giuseppina; Annagiulia, Bottaccioli; Zerbinati, Chiara. - In: JOURNAL OF ALZHEIMER’S DISEASE & PARKINSONISM. - ISSN 2161-0460. - ELETTRONICO. - 2:(2012), p. 1000e119. [10.4172/2161-0460.1000e119]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/516515
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact